High density lipoprotein inhibits the activation of sterol regulatory element-binding protein-1 in cultured cells. 2010

Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
Department of Nutrition and Metabolism, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima-city, Japan. zyousyou8@yahoo.co.jp

A link between cellular uptake of high density lipoprotein (HDL) and regulation of sterol regulatory element-binding protein-1 (SREBP-1) was investigated in vitro. HDL decreased nuclear SREBP-1 levels as well as SREBP-1 target gene expression in HepG2 and HEK293 cells. However, HDL did not repress an exogenously expressed, constitutively active form of SREBP-1. HDL increased cellular cholesterol levels, and cellular cholesterol depletion by methyl-beta-cyclodextrin abolished the effects of HDL. These results suggest that HDL inhibits the activation of SREBP-1 through a cholesterol-dependent mechanism, which may play an important role in regulating lipid synthetic pathways mediated by SREBP-1.

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008297 Male Males
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000103 Acetyl-CoA Carboxylase A carboxylating enzyme that catalyzes the conversion of ATP, acetyl-CoA, and HCO3- to ADP, orthophosphate, and malonyl-CoA. It is a biotinyl-protein that also catalyzes transcarboxylation. The plant enzyme also carboxylates propanoyl-CoA and butanoyl-CoA (From Enzyme Nomenclature, 1992) EC 6.4.1.2. Acetyl Coenzyme A Carboxylase,Acetyl CoA Carboxylase,Carboxylase, Acetyl-CoA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013230 Stearoyl-CoA Desaturase An enzyme that catalyzes the formation of oleoyl-CoA, A, and water from stearoyl-CoA, AH2, and oxygen where AH2 is an unspecified hydrogen donor. Stearyl-CoA Desaturase,Stearate Desaturase,delta-9 Desaturase,Desaturase, Stearate,Desaturase, Stearoyl-CoA,Desaturase, Stearyl-CoA,Desaturase, delta-9,Stearoyl CoA Desaturase,Stearyl CoA Desaturase,delta 9 Desaturase
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic
D015971 Gene Expression Regulation, Enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymologic Gene Expression Regulation,Regulation of Gene Expression, Enzymologic,Regulation, Gene Expression, Enzymologic

Related Publications

Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
January 2001, Endocrinology,
Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
April 2018, Obesity (Silver Spring, Md.),
Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
June 2006, Journal of molecular biology,
Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
January 1995, The Journal of biological chemistry,
Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
January 1999, Biochimica et biophysica acta,
Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
August 2012, Experimental and therapeutic medicine,
Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
December 2001, Endocrinology,
Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
June 1995, Proceedings of the National Academy of Sciences of the United States of America,
Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
October 2001, Molecular endocrinology (Baltimore, Md.),
Masaki Yoshida, and Nagakatsu Harada, and Keiko Yoshida, and Tadahiko Nakagawa, and Takaaki Shimohata, and Kazuaki Mawatari, and Akira Takahashi, and Hiroshi Sakaue, and Yutaka Nakaya
January 2019, Cellular signalling,
Copied contents to your clipboard!